Thierry Passeron

14.0k total citations · 2 hit papers
281 papers, 7.1k citations indexed

About

Thierry Passeron is a scholar working on Dermatology, Cell Biology and Immunology. According to data from OpenAlex, Thierry Passeron has authored 281 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Dermatology, 119 papers in Cell Biology and 62 papers in Immunology. Recurrent topics in Thierry Passeron's work include melanin and skin pigmentation (112 papers), Skin Protection and Aging (87 papers) and Dermatologic Treatments and Research (45 papers). Thierry Passeron is often cited by papers focused on melanin and skin pigmentation (112 papers), Skin Protection and Aging (87 papers) and Dermatologic Treatments and Research (45 papers). Thierry Passeron collaborates with scholars based in France, United States and Germany. Thierry Passeron's co-authors include J.‐P. Lacour, Jean‐Paul Ortonne, Jean Krutmann, Éric Fontas, Vincent J. Hearing, Bruno Bernard, Anne Bouloc, Philippe Bahadoran, Gabrielle Sore and Henri Montaudié and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Thierry Passeron

247 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The skin aging exposome

2016 519 citations Jean Krutmann, Thierry Passeron et al. profile →
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

2022 133 citations David Rosmarin, Thierry Passeron et al. profile →

Peers

Countries citing papers authored by Thierry Passeron

Since Specialization

Citations

This map shows the geographic impact of Thierry Passeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Passeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Passeron more than expected).

Fields of papers citing papers by Thierry Passeron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Passeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Passeron. The network helps show where Thierry Passeron may publish in the future.

Co-authorship network of co-authors of Thierry Passeron

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Passeron. A scholar is included among the top collaborators of Thierry Passeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Passeron. Thierry Passeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combination of Baricitinib and Phototherapy in Adults With Active Vitiligo 2025 ·JAMA Dermatology ·Julien Sénéschal, (unknown), (unknown), J. Mazereeuw‐Hautier, (unknown), (unknown), Khaled Ezzedine, Thierry Passeron, Katia Boniface	6
2	Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with Vitiligo 2025 ·Dermatology and Therapy ·David Rosmarin, Amit G. Pandya, Thierry Passeron, Seth Forman, Jacek Zdybski, (unknown), (unknown), Kim Papp, Anthony A. Nuara, Deanna Kornacki, (unknown), Haobo Ren, John E. Harris, Khaled Ezzedine	0
3	Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials 2024 ·British Journal of Dermatology ·Christos C. Zouboulis, Thierry Passeron, David M. Pariser, Magdalena B. Wozniak, Xianjun Li, Lorenz Uhlmann, Iryna Lobach, (unknown), Shoba Ravichandran, Ivette Alarcón, Annamaria Offidani, (unknown), Pedro Mendes‐Bastos	10
4	CLEC12B Regulates Melanocyte Immunity and Homeostasis in the Skin through the Signal Transducer and Activator of Transcription 1/IRF1 Axis 2024 ·Journal of Investigative Dermatology ·(unknown), Hanene Bzioueche, M. Heim, Yann Chéli, Laura Sormani, Els Verhoeyen, Alexandre Stella, Odile Burlet‐Schiltz, Stéphane Rocchi, Lionel Larue, Yoann Rombouts, Bernd Lepenies, Thierry Passeron, Meri K. Tulić	0
5	54736 Prevalence of solar lentigo, impact on quality of life and social stigmatization: Results of the first large international survey 2024 ·Journal of the American Academy of Dermatology ·Delphine Kérob, Thierry Passeron, Brigitte Dréno, Wei Liu, Akimichi Morita, (unknown), Fatimata Ly, Susana Puig, Sérgio Schalka, Hee Young Kang, Henry W. Lim	0
6	Sun Exposure Behaviors and Knowledge Among the At‐Risk Population: Results From an International Survey, the HELIOS Project 2024 ·Photodermatology Photoimmunology & Photomedicine ·Thierry Passeron, Brigitte Dréno, Susana Puig, Chee Leok Goh, Hee Young Kang, (unknown), Akimichi Morita, Jorge Ocampo‐Candiani, Sérgio Schalka, Wei Liu, (unknown), (unknown), Delphine Kérob, Henry W. Lim, Jean Krutmann	1
7	Treatment of Bullous Pemphigoid with Avdoralimab: Multicenter, Randomized, Open-Labeled Phase 2 Study 2024 ·SHILAP Revista de lepidopterología ·Thierry Passeron, Éric Fontas, T. Boyé, M.‐A. Richard, E. Delaporte, O. Dereure	2
8	A Bayesian network meta‐analysis of 14 molecules inhibiting UV daylight‐induced pigmentation 2024 ·Journal of the European Academy of Dermatology and Venereology ·(unknown), Frédéric Flament, (unknown), Peggy Sextius, (unknown), Yan Wang, (unknown), (unknown), (unknown), David Amar, (unknown), Nina G. Jablonski, Thierry Passeron	3
9	Exploring the impact of solar radiation on skin microbiome to develop improved photoprotection strategies 2024 ·Photochemistry and Photobiology ·Yolanda Gilaberte, Jaime Piquero‐Casals, Sérgio Schalka, Giovanni Leone, Anthony Brown, Carles Trullàs, (unknown), Henry W. Lim, Jean Krutmann, Thierry Passeron	4
10	PCR256 Correlation of Patient-Reported Vitiligo Noticeability Scale With Physician-Assessed Facial Vitiligo Area Scoring Index Responses: Post Hoc Analyses From the True-V Trials of Ruxolitinib Cream in Vitiligo 2023 ·Value in Health ·Albert Wolkerstorfer, Thierry Passeron, David Rosmarin, Molly Sebastian, Sujal R. Desai, (unknown), Julien Sénéschal, Kathleen Butler, Kristen Bibeau, (unknown), Amit G. Pandya	0
11	Deucravacitinib long-term efficacy with continuous treatment in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program 2023 ·SKIN The Journal of Cutaneous Medicine ·Mark Lebwohl, Richard B. Warren, Howard Sofen, (unknown), C. Paul, Jacek C. Szepietowski, Lynda Spelman, Thierry Passeron, Elizabeth Colston, (unknown), Andrew Napoli, Renata M. Kisa, Subhashis Banerjee, Alan Menter, Diamant Thaçi, Andrew Blauvelt	3
12	Sun exposure behaviours as a compromise to paradoxical injunctions: Insight from a worldwide survey 2023 ·Journal of the European Academy of Dermatology and Venereology ·Thierry Passeron, Henry W. Lim, Chee Leok Goh, Hee Young Kang, Fatimata Ly, Akimichi Morita, Jorge Ocampo‐Candiani, Susana Puig, Sérgio Schalka, Wei Liu, (unknown), (unknown), Delphine Kérob, Brigitte Dréno, Jean Krutmann	9
13	Consensus on the safety and risks of laser and intense pulse light treatments in patients with vitiligo: An e-Delphi study 2023 ·Journal of the American Academy of Dermatology ·(unknown), Michelle Rodrigues, (unknown), (unknown), Marwa Abdallah, Jung Min Bae, Marcel W. Bekkenk, Caio César Silva de Castro, (unknown), Samia Esmat, Khaled Ezzedine, Nanja van Geel, Iltefat Hamzavi, Giovanni Leone, Amit G. Pandya, Thierry Passeron, Noufal Raboobee, Julien Sénéschal, (unknown), Albert Wolkerstorfer	1
14	Inhibition of T-cell activity in alopecia areata: recent developments and new directions 2023 ·Frontiers in Immunology ·Thierry Passeron, Brett King, Julien Sénéschal, Martin Steinhoff, Ali Jabbari, Manabu Ohyama, Desmond J. Tobin, Simran Randhawa, Aaron Winkler, Jean‐Baptiste Telliez, David E. Martin, (unknown)	40
15	43912 Facial Vitiligo Area Scoring Index Response Maintenance or Shift During 52 Weeks of Ruxolitinib Cream Treatment for Vitiligo: Pooled Analysis of the TRuE-V Phase 3 Studies 2023 ·Journal of the American Academy of Dermatology ·John E. Harris, David Rosmarin, Julien Sénéschal, Amit G. Pandya, Mark Lebwohl, Khaled Ezzedine, Deanna Kornacki, Haobo Ren, Kathleen Butler, Thierry Passeron	1
16	Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials 2022 ·British Journal of Dermatology ·Brett King, Arash Mostaghimi, Yutaka Shimomura, Abraham Zlotogorski, Gwang Seong Choi, Ulrike Blume‐Peytavi, Thierry Passeron, Katrin Holzwarth, Yves Dutronc, Jill Shwed McCollam, Fan Emily Yang, Sarah Stanley, Wen-Shuo Wu, Rodney Sinclair	37
17	Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma 2021 ·EMBO Molecular Medicine ·Ilona Berestjuk, (unknown), (unknown), (unknown), (unknown), Virginie Prod’homme, Mickaël Ohanna, (unknown), Aude Mallavialle, Frédéric Larbret, Sabrina Pisano, Stéphane Audebert, Thierry Passeron, Cédric Gaggioli, Christophe A. Girard, Marcel Deckert, Sophie Tartare‐Deckert	49
18	Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies 2021 ·Cell Death and Disease ·Emilie Jaune, (unknown), Cyril Ronco, (unknown), Patricia Abbe, (unknown), (unknown), Guillaume E. Béranger, (unknown), Frédéric Bost, Maéva Gesson, Meri K. Tulić, Paul Hofman, Robert Ballotti, Thierry Passeron, Thomas Botton, Rachid Benhida, Stéphane Rocchi	19
19	Photoprotection of the future: challenges and opportunities 2020 ·Journal of the European Academy of Dermatology and Venereology ·Jean Krutmann, Thierry Passeron, Yolanda Gilaberte, Corinne Granger, Giovanni Leone, Mridvika Narda, Sérgio Schalka, Carles Trullàs, Philippe Masson, Henry W. Lim	52
20	Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo 2019 ·Nature Communications ·Meri K. Tulić, (unknown), Yann Chéli, Arnaud Jacquel, Carmelo Luci, Nathalie Cardot‐Leccia, (unknown), Patricia Abbe, Maéva Gesson, Laura Sormani, Claire Regazzetti, Guillaume E. Béranger, (unknown), Caroline Pons, A. Khemis, Robert Ballotti, Corine Bertolotto, Stéphane Rocchi, Thierry Passeron	123

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact